Peptide Therapeutics Market Size, Share, Growth and Trends 2034

Peptide Therapeutics Market

Peptide Therapeutics Market By Route Of Administration (Parenteral, Oral, and Others), By Type (Innovative and Generic), By Type Of Manufacturers (In-House and Outsourced), By Type Of Molecule (Vasopressin, Somatostatin, Calcitonin, Immunopeptide, Natriuretic, and Others), By Technology (Liquid Phase, Solid Phase, and Hybrid Phase), By Application (Cancer, Cardiovascular Disease, Metabolic Disease, Respiratory Disease, Infectious Disease, and Others), and By Region: Global and Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, and Forecasts 2025 - 2034

Category: Healthcare Report Format : PDF Pages: 199 Report Code: ZMR-3439 Published Date: Apr-2025 Status : Published
Market Size in 2024 Market Forecast in 2034 CAGR (in %) Base Year
USD 117.26 Billion USD 332.95 Billion 11% 2024

Table Of Content

  • Chapter 1. Preface
    • 1.1 Report Description and Scope
    • 1.2 Research scope
    • 1.3 Research methodology
      • 1.3.1 Market Research Type
      • 1.3.2 Market research methodology
  • Chapter 2. Executive Summary
    • 2.1 Global Peptide Therapeutics Market, (2022 - 2028) (USD Billion)
    • 2.2 Global Peptide Therapeutics Market : snapshot
  • Chapter 3. Global Peptide Therapeutics Market - Industry Analysis
    • 3.1 Peptide Therapeutics Market: Market Dynamics
    • 3.2 Market Drivers
      • 3.2.1 Increase in cancer patients and respiratory disorders to propel the global market growth
    • 3.3 Market Restraints
      • 3.3.1. Unstable nature of peptide therapeutics likely to hamper market growth
    • 3.4 Market Opportunities
      • 3.4.1. Advent of multi-functional peptide therapeutics to bring growth prospects in coming period
    • 3.5 Market Challenges
      • 3.5.1. Shift towards proteomics
      • 3.5.2. high cost of peptide therapeutics along with quick expiration of patents to challenge the global market growth
    • 3.6 Porter’s Five Forces Analysis
    • 3.7 Market Attractiveness Analysis
      • 3.7.1 Market attractiveness analysis By Route of Administration
      • 3.7.2 Market attractiveness analysis By Type
      • 3.7.3 Market attractiveness analysis By Type of Manufacturers
      • 3.7.4 Market attractiveness analysis By Type of Molecule
      • 3.7.5 Market attractiveness analysis By Technology
      • 3.7.6 Market attractiveness analysis By Application
  • Chapter 4. Global Peptide Therapeutics Market- Competitive Landscape
    • 4.1 Company market share analysis
      • 4.1.1 Global Peptide Therapeutics Market: company market share, 2021
    • 4.2 Strategic development
      • 4.2.1 Acquisitions & mergers
      • 4.2.2 New Product launches
      • 4.2.3 Agreements, partnerships, cullaborations, and joint ventures
      • 4.2.4 Research and development and Regional expansion
    • 4.3 Price trend analysis
  • Chapter 5. Global Peptide Therapeutics Market - Route of Administration Analysis
    • 5.1 Global Peptide Therapeutics Market overview: By Route of Administration
      • 5.1.1 Global Peptide Therapeutics Market share, By Route of Administration, 2021 and 2028
    • 5.2 Parenteral
      • 5.2.1 Global Peptide Therapeutics Market by Parenteral, 2022 - 2028 (USD Billion)
    • 5.3 Oral
      • 5.3.1 Global Peptide Therapeutics Market by Oral, 2022 - 2028 (USD Billion)
    • 5.4 Others
      • 5.4.1 Global Peptide Therapeutics Market by Others, 2022 - 2028 (USD Billion)
  • Chapter 6. Global Peptide Therapeutics Market - Type Analysis
    • 6.1 Global Peptide Therapeutics Market overview: By Type
      • 6.1.1 Global Peptide Therapeutics Market share, By Type, 2021 and 2028
    • 6.2 Innovative
      • 6.2.1 Global Peptide Therapeutics Market by Innovative, 2022 - 2028 (USD Billion)
    • 6.3 Generic
      • 6.3.1 Global Peptide Therapeutics Market by Generic, 2022 - 2028 (USD Billion)
  • Chapter 7. Global Peptide Therapeutics Market - Type of Manufacturers Analysis
    • 7.1 Global Peptide Therapeutics Market overview: By Type of Manufacturers
      • 7.1.1 Global Peptide Therapeutics Market share, By Type of Manufacturers, 2021 and 2028
    • 7.2 In-house
      • 7.2.1 Global Peptide Therapeutics Market by In-house, 2022 - 2028 (USD Billion)
    • 7.3 Outsourced
      • 7.3.1 Global Peptide Therapeutics Market by Outsourced, 2022 - 2028 (USD Billion)
  • Chapter 8. Global Peptide Therapeutics Market - Type of Molecule Analysis
    • 8.1 Global Peptide Therapeutics Market overview: By Type of Molecule
      • 8.1.1 Global Peptide Therapeutics Market share, By Type of Molecule, 2021 and 2028
    • 8.2 Vasopressin
      • 8.2.1 Global Peptide Therapeutics Market by Vasopressin, 2022 - 2028 (USD Billion)
    • 8.3 Somatostatin
      • 8.3.1 Global Peptide Therapeutics Market by Somatostatin, 2022 - 2028 (USD Billion)
    • 8.4 Calcitonin
      • 8.4.1 Global Peptide Therapeutics Market by Calcitonin, 2022 - 2028 (USD Billion)
    • 8.5 Immunopeptide
      • 8.5.1 Global Peptide Therapeutics Market by Immunopeptide, 2022 - 2028 (USD Billion)
    • 8.6 Natriuretic
      • 8.6.1 Global Peptide Therapeutics Market by Natriuretic, 2022 - 2028 (USD Billion)
    • 8.7 Others
      • 8.7.1 Global Peptide Therapeutics Market by Others, 2022 - 2028 (USD Billion)
  • Chapter 9. Global Peptide Therapeutics Market - Technology Analysis
    • 9.1 Global Peptide Therapeutics Market overview: By Technology
      • 9.1.1 Global Peptide Therapeutics Market share, By Technology, 2021 and 2028
    • 9.2 Liquid phase
      • 9.2.1 Global Peptide Therapeutics Market by Liquid phase, 2022 - 2028 (USD Billion)
    • 9.3 Solid-phase
      • 9.3.1 Global Peptide Therapeutics Market by Solid-phase, 2022 - 2028 (USD Billion)
    • 9.4 Hybrid phase
      • 9.4.1 Global Peptide Therapeutics Market by Hybrid phase, 2022 - 2028 (USD Billion)
  • Chapter 10. Global Peptide Therapeutics Market - Application Analysis
    • 10.1 Global Peptide Therapeutics Market overview: By Application
      • 10.1.1 Global Peptide Therapeutics Market share, By Application, 2021 and 2028
    • 10.2 Cancer
      • 10.2.1 Global Peptide Therapeutics Market by Cancer, 2022 - 2028 (USD Billion)
    • 10.3 Cardiovascular Disease
      • 10.3.1 Global Peptide Therapeutics Market by Cardiovascular Disease, 2022 - 2028 (USD Billion)
    • 10.4 Metabolic Disease
      • 10.4.1 Global Peptide Therapeutics Market by Metabolic Disease, 2022 - 2028 (USD Billion)
    • 10.5 Respiratory Disease
      • 10.5.1 Global Peptide Therapeutics Market by Respiratory Disease, 2022 - 2028 (USD Billion)
    • 10.6 Infectious Disease
      • 10.6.1 Global Peptide Therapeutics Market by Infectious Disease, 2022 - 2028 (USD Billion)
    • 10.7 Others
      • 10.7.1 Global Peptide Therapeutics Market by Others, 2022 - 2028 (USD Billion)
  • Chapter 11. Peptide Therapeutics Market - Regional Analysis
    • 11.1 Global Peptide Therapeutics Market Regional Overview
    • 11.2 Global Peptide Therapeutics Market Share, by Region, 2021 & 2028 (USD Billion)
    • 11.3. North America
      • 11.3.1 North America Peptide Therapeutics Market, 2022 - 2028 (USD Billion)
        • 11.3.1.1 North America Peptide Therapeutics Market, by Country, 2022 - 2028 (USD Billion)
    • 11.4 North America Peptide Therapeutics Market, by Route of Administration, 2022 - 2028
      • 11.4.1 North America Peptide Therapeutics Market, by Route of Administration, 2022 - 2028 (USD Billion)
    • 11.5 North America Peptide Therapeutics Market, by Type, 2022 - 2028
      • 11.5.1 North America Peptide Therapeutics Market, by Type, 2022 - 2028 (USD Billion)
    • 11.6 North America Peptide Therapeutics Market, by Type of Manufacturers, 2022 - 2028
      • 11.6.1 North America Peptide Therapeutics Market, by Type of Manufacturers, 2022 - 2028 (USD Billion)
    • 11.7 North America Peptide Therapeutics Market, by Type of Molecule, 2022 - 2028
      • 11.7.1 North America Peptide Therapeutics Market, by Type of Molecule, 2022 - 2028 (USD Billion)
    • 11.8 North America Peptide Therapeutics Market, by Technology, 2022 - 2028
      • 11.8.1 North America Peptide Therapeutics Market, by Technology, 2022 - 2028 (USD Billion)
    • 11.9 North America Peptide Therapeutics Market, by Application, 2022 - 2028
      • 11.9.1 North America Peptide Therapeutics Market, by Application, 2022 - 2028 (USD Billion)
    • 11.4. Europe
      • 11.4.2 Europe Peptide Therapeutics Market, 2022 - 2028 (USD Billion)
        • 11.4.2.1 Europe Peptide Therapeutics Market, by Country, 2022 - 2028 (USD Billion)
    • 11.4 Europe Peptide Therapeutics Market, by Route of Administration, 2022 - 2028
      • 11.4.1 Europe Peptide Therapeutics Market, by Route of Administration, 2022 - 2028 (USD Billion)
    • 11.5 Europe Peptide Therapeutics Market, by Type, 2022 - 2028
      • 11.5.1 Europe Peptide Therapeutics Market, by Type, 2022 - 2028 (USD Billion)
    • 11.6 Europe Peptide Therapeutics Market, by Type of Manufacturers, 2022 - 2028
      • 11.6.1 Europe Peptide Therapeutics Market, by Type of Manufacturers, 2022 - 2028 (USD Billion)
    • 11.7 Europe Peptide Therapeutics Market, by Type of Molecule, 2022 - 2028
      • 11.7.1 Europe Peptide Therapeutics Market, by Type of Molecule, 2022 - 2028 (USD Billion)
    • 11.8 Europe Peptide Therapeutics Market, by Technology, 2022 - 2028
      • 11.8.1 Europe Peptide Therapeutics Market, by Technology, 2022 - 2028 (USD Billion)
    • 11.9 Europe Peptide Therapeutics Market, by Application, 2022 - 2028
      • 11.9.1 Europe Peptide Therapeutics Market, by Application, 2022 - 2028 (USD Billion)
    • 11.5. Asia Pacific
      • 11.5.3 Asia Pacific Peptide Therapeutics Market, 2022 - 2028 (USD Billion)
        • 11.5.3.1 Asia Pacific Peptide Therapeutics Market, by Country, 2022 - 2028 (USD Billion)
    • 11.4 Asia Pacific Peptide Therapeutics Market, by Route of Administration, 2022 - 2028
      • 11.4.1 Asia Pacific Peptide Therapeutics Market, by Route of Administration, 2022 - 2028 (USD Billion)
    • 11.5 Asia Pacific Peptide Therapeutics Market, by Type, 2022 - 2028
      • 11.5.1 Asia Pacific Peptide Therapeutics Market, by Type, 2022 - 2028 (USD Billion)
    • 11.6 Asia Pacific Peptide Therapeutics Market, by Type of Manufacturers, 2022 - 2028
      • 11.6.1 Asia Pacific Peptide Therapeutics Market, by Type of Manufacturers, 2022 - 2028 (USD Billion)
    • 11.7 Asia Pacific Peptide Therapeutics Market, by Type of Molecule, 2022 - 2028
      • 11.7.1 Asia Pacific Peptide Therapeutics Market, by Type of Molecule, 2022 - 2028 (USD Billion)
    • 11.8 Asia Pacific Peptide Therapeutics Market, by Technology, 2022 - 2028
      • 11.8.1 Asia Pacific Peptide Therapeutics Market, by Technology, 2022 - 2028 (USD Billion)
    • 11.9 Asia Pacific Peptide Therapeutics Market, by Application, 2022 - 2028
      • 11.9.1 Asia Pacific Peptide Therapeutics Market, by Application, 2022 - 2028 (USD Billion)
    • 11.6. Latin America
      • 11.6.4 Latin America Peptide Therapeutics Market, 2022 - 2028 (USD Billion)
        • 11.6.4.1 Latin America Peptide Therapeutics Market, by Country, 2022 - 2028 (USD Billion)
    • 11.4 Latin America Peptide Therapeutics Market, by Route of Administration, 2022 - 2028
      • 11.4.1 Latin America Peptide Therapeutics Market, by Route of Administration, 2022 - 2028 (USD Billion)
    • 11.5 Latin America Peptide Therapeutics Market, by Type, 2022 - 2028
      • 11.5.1 Latin America Peptide Therapeutics Market, by Type, 2022 - 2028 (USD Billion)
    • 11.6 Latin America Peptide Therapeutics Market, by Type of Manufacturers, 2022 - 2028
      • 11.6.1 Latin America Peptide Therapeutics Market, by Type of Manufacturers, 2022 - 2028 (USD Billion)
    • 11.7 Latin America Peptide Therapeutics Market, by Type of Molecule, 2022 - 2028
      • 11.7.1 Latin America Peptide Therapeutics Market, by Type of Molecule, 2022 - 2028 (USD Billion)
    • 11.8 Latin America Peptide Therapeutics Market, by Technology, 2022 - 2028
      • 11.8.1 Latin America Peptide Therapeutics Market, by Technology, 2022 - 2028 (USD Billion)
    • 11.9 Latin America Peptide Therapeutics Market, by Application, 2022 - 2028
      • 11.9.1 Latin America Peptide Therapeutics Market, by Application, 2022 - 2028 (USD Billion)
    • 11.7. The Middle-East and Africa
      • 11.7.5 The Middle-East and Africa Peptide Therapeutics Market, 2022 - 2028 (USD Billion)
        • 11.7.5.1 The Middle-East and Africa Peptide Therapeutics Market, by Country, 2022 - 2028 (USD Billion)
    • 11.4 The Middle-East and Africa Peptide Therapeutics Market, by Route of Administration, 2022 - 2028
      • 11.4.1 The Middle-East and Africa Peptide Therapeutics Market, by Route of Administration, 2022 - 2028 (USD Billion)
    • 11.5 The Middle-East and Africa Peptide Therapeutics Market, by Type, 2022 - 2028
      • 11.5.1 The Middle-East and Africa Peptide Therapeutics Market, by Type, 2022 - 2028 (USD Billion)
    • 11.6 The Middle-East and Africa Peptide Therapeutics Market, by Type of Manufacturers, 2022 - 2028
      • 11.6.1 The Middle-East and Africa Peptide Therapeutics Market, by Type of Manufacturers, 2022 - 2028 (USD Billion)
    • 11.7 The Middle-East and Africa Peptide Therapeutics Market, by Type of Molecule, 2022 - 2028
      • 11.7.1 The Middle-East and Africa Peptide Therapeutics Market, by Type of Molecule, 2022 - 2028 (USD Billion)
    • 11.8 The Middle-East and Africa Peptide Therapeutics Market, by Technology, 2022 - 2028
      • 11.8.1 The Middle-East and Africa Peptide Therapeutics Market, by Technology, 2022 - 2028 (USD Billion)
    • 11.9 The Middle-East and Africa Peptide Therapeutics Market, by Application, 2022 - 2028
      • 11.9.1 The Middle-East and Africa Peptide Therapeutics Market, by Application, 2022 - 2028 (USD Billion)
  • Chapter 12. Company Profiles
    • 12.1 Teva Pharmaceutical Industries
      • 12.1.1 Overview
      • 12.1.2 Financials
      • 12.1.3 Product Portfolio
      • 12.1.4 Business Strategy
      • 12.1.5 Recent Developments
    • 12.2 AstraZeneca
      • 12.2.1 Overview
      • 12.2.2 Financials
      • 12.2.3 Product Portfolio
      • 12.2.4 Business Strategy
      • 12.2.5 Recent Developments
    • 12.3 Sanofi S.A
      • 12.3.1 Overview
      • 12.3.2 Financials
      • 12.3.3 Product Portfolio
      • 12.3.4 Business Strategy
      • 12.3.5 Recent Developments
    • 12.4 Amazen Inc.
      • 12.4.1 Overview
      • 12.4.2 Financials
      • 12.4.3 Product Portfolio
      • 12.4.4 Business Strategy
      • 12.4.5 Recent Developments
    • 12.5 Takeda Pharmaceutical
      • 12.5.1 Overview
      • 12.5.2 Financials
      • 12.5.3 Product Portfolio
      • 12.5.4 Business Strategy
      • 12.5.5 Recent Developments
    • 12.6 Ipsen S.A
      • 12.6.1 Overview
      • 12.6.2 Financials
      • 12.6.3 Product Portfolio
      • 12.6.4 Business Strategy
      • 12.6.5 Recent Developments
    • 12.7 Merck & Co.
      • 12.7.1 Overview
      • 12.7.2 Financials
      • 12.7.3 Product Portfolio
      • 12.7.4 Business Strategy
      • 12.7.5 Recent Developments
    • 12.8 Novo Nordisk A/S
      • 12.8.1 Overview
      • 12.8.2 Financials
      • 12.8.3 Product Portfolio
      • 12.8.4 Business Strategy
      • 12.8.5 Recent Developments
    • 12.9 GlaxoSmithKline plc
      • 12.9.1 Overview
      • 12.9.2 Financials
      • 12.9.3 Product Portfolio
      • 12.9.4 Business Strategy
      • 12.9.5 Recent Developments
    • 12.10 Ever Neuro Pharma
      • 12.10.1 Overview
      • 12.10.2 Financials
      • 12.10.3 Product Portfolio
      • 12.10.4 Business Strategy
      • 12.10.5 Recent Developments
    • 12.11 Eli Lilly and Company
      • 12.11.1 Overview
      • 12.11.2 Financials
      • 12.11.3 Product Portfolio
      • 12.11.4 Business Strategy
      • 12.11.5 Recent Developments
    • 12.12 CordenPharma International.
      • 12.12.1 Overview
      • 12.12.2 Financials
      • 12.12.3 Product Portfolio
      • 12.12.4 Business Strategy
      • 12.12.5 Recent Developments

Table Of Figures

  • 1. Market research Type
  • 2. Market research methodology
  • 3. Global Peptide Therapeutics Market, 2022 - 2028 (USD Billion)
  • 4. Porter’s Five Forces Analysis
  • 5. Global Peptide Therapeutics Market attractiveness, By Route of Administration
  • 6. Global Peptide Therapeutics Market attractiveness, By Type
  • 7. Global Peptide Therapeutics Market attractiveness, By Type of Manufacturers
  • 8. Global Peptide Therapeutics Market attractiveness, By Type of Molecule
  • 9. Global Peptide Therapeutics Market attractiveness, By Technology
  • 10. Global Peptide Therapeutics Market attractiveness, By Application
  • 11. Global Peptide Therapeutics Market share by Route of Administration, 2022 and 2028 (USD Billion)
  • 12. Global Peptide Therapeutics Market by Parenteral, 2022 - 2028 (USD Billion)
  • 13. Global Peptide Therapeutics Market by Oral, 2022 - 2028 (USD Billion)
  • 14. Global Peptide Therapeutics Market by Others, 2022 - 2028 (USD Billion)
  • 15. Global Peptide Therapeutics Market share by Type, 2022 and 2028 (USD Billion)
  • 16. Global Peptide Therapeutics Market by Innovative, 2022 - 2028 (USD Billion)
  • 17. Global Peptide Therapeutics Market by Generic, 2022 - 2028 (USD Billion)
  • 18. Global Peptide Therapeutics Market share by Type of Manufacturers, 2022 and 2028 (USD Billion)
  • 19. Global Peptide Therapeutics Market by In-house, 2022 - 2028 (USD Billion)
  • 20. Global Peptide Therapeutics Market by Outsourced, 2022 - 2028 (USD Billion)
  • 21. Global Peptide Therapeutics Market share by Type of Molecule, 2022 and 2028 (USD Billion)
  • 22. Global Peptide Therapeutics Market by Vasopressin, 2022 - 2028 (USD Billion)
  • 23. Global Peptide Therapeutics Market by Somatostatin, 2022 - 2028 (USD Billion)
  • 24. Global Peptide Therapeutics Market by Calcitonin, 2022 - 2028 (USD Billion)
  • 25. Global Peptide Therapeutics Market by Immunopeptide, 2022 - 2028 (USD Billion)
  • 26. Global Peptide Therapeutics Market by Natriuretic, 2022 - 2028 (USD Billion)
  • 27. Global Peptide Therapeutics Market by Others, 2022 - 2028 (USD Billion)
  • 28. Global Peptide Therapeutics Market share by Technology, 2022 and 2028 (USD Billion)
  • 29. Global Peptide Therapeutics Market by Liquid phase, 2022 - 2028 (USD Billion)
  • 30. Global Peptide Therapeutics Market by Solid-phase, 2022 - 2028 (USD Billion)
  • 31. Global Peptide Therapeutics Market by Hybrid phase, 2022 - 2028 (USD Billion)
  • 32. Global Peptide Therapeutics Market share by Application, 2022 and 2028 (USD Billion)
  • 33. Global Peptide Therapeutics Market by Cancer, 2022 - 2028 (USD Billion)
  • 34. Global Peptide Therapeutics Market by Cardiovascular Disease, 2022 - 2028 (USD Billion)
  • 35. Global Peptide Therapeutics Market by Metabolic Disease, 2022 - 2028 (USD Billion)
  • 36. Global Peptide Therapeutics Market by Respiratory Disease, 2022 - 2028 (USD Billion)
  • 37. Global Peptide Therapeutics Market by Infectious Disease, 2022 - 2028 (USD Billion)
  • 38. Global Peptide Therapeutics Market by Others, 2022 - 2028 (USD Billion)
  • 39. Global Peptide Therapeutics Market share, by Region, 2022 and 2028
  • 40. North America Peptide Therapeutics Market, 2022 - 2028 (USD Billion)
  • 41. Europe Peptide Therapeutics Market, 2022 - 2028 (USD Billion)
  • 42. Asia Pacific Peptide Therapeutics Market, 2022 - 2028 (USD Billion)
  • 43. Latin America Peptide Therapeutics Market, 2022 - 2028 (USD Billion)
  • 44. The Middle-East and Africa Peptide Therapeutics Market, 2022 - 2028 (USD Billion)

Table Of Tables

  • 1. Global Peptide Therapeutics Market: Snapshot
  • 2. Drivers of the Peptide Therapeutics Market: impact analysis
  • 3. North America Peptide Therapeutics Market revenue, By Route of Administration, 2022 - 2028 (USD Billion)
  • 4. North America Peptide Therapeutics Market revenue, By Type, 2022 - 2028 (USD Billion)
  • 5. North America Peptide Therapeutics Market revenue, By Type of Manufacturers, 2022 - 2028 (USD Billion)
  • 6. North America Peptide Therapeutics Market revenue, By Type of Molecule, 2022 - 2028 (USD Billion)
  • 7. North America Peptide Therapeutics Market revenue, By Technology, 2022 - 2028 (USD Billion)
  • 8. North America Peptide Therapeutics Market revenue, By Application, 2022 - 2028 (USD Billion)
  • 9. U.S. Peptide Therapeutics Market revenue, By Route of Administration, 2022 - 2028 (USD Billion)
  • 10. U.S. Peptide Therapeutics Market revenue, By Type, 2022 - 2028 (USD Billion)
  • 11. U.S. Peptide Therapeutics Market revenue, By Type of Manufacturers, 2022 - 2028 (USD Billion)
  • 12. U.S. Peptide Therapeutics Market revenue, By Type of Molecule, 2022 - 2028 (USD Billion)
  • 13. U.S. Peptide Therapeutics Market revenue, By Technology, 2022 - 2028 (USD Billion)
  • 14. U.S. Peptide Therapeutics Market revenue, By Application, 2022 - 2028 (USD Billion)
  • 15. Canada Peptide Therapeutics Market revenue, By Route of Administration, 2022 - 2028 (USD Billion)
  • 16. Canada Peptide Therapeutics Market revenue, By Type, 2022 - 2028 (USD Billion)
  • 17. Canada Peptide Therapeutics Market revenue, By Type of Manufacturers, 2022 - 2028 (USD Billion)
  • 18. Canada Peptide Therapeutics Market revenue, By Type of Molecule, 2022 - 2028 (USD Billion)
  • 19. Canada Peptide Therapeutics Market revenue, By Technology, 2022 - 2028 (USD Billion)
  • 20. Canada Peptide Therapeutics Market revenue, By Application, 2022 - 2028 (USD Billion)
  • 21. Europe Peptide Therapeutics Market revenue, By Route of Administration, 2022 - 2028 (USD Billion)
  • 22. Europe Peptide Therapeutics Market revenue, By Type, 2022 - 2028 (USD Billion)
  • 23. Europe Peptide Therapeutics Market revenue, By Type of Manufacturers, 2022 - 2028 (USD Billion)
  • 24. Europe Peptide Therapeutics Market revenue, By Type of Molecule, 2022 - 2028 (USD Billion)
  • 25. Europe Peptide Therapeutics Market revenue, By Technology, 2022 - 2028 (USD Billion)
  • 26. Europe Peptide Therapeutics Market revenue, By Application, 2022 - 2028 (USD Billion)
  • 27. Germany Peptide Therapeutics Market revenue, By Route of Administration, 2022 - 2028 (USD Billion)
  • 28. Germany Peptide Therapeutics Market revenue, By Type, 2022 - 2028 (USD Billion)
  • 29. Germany Peptide Therapeutics Market revenue, By Type of Manufacturers, 2022 - 2028 (USD Billion)
  • 30. Germany Peptide Therapeutics Market revenue, By Type of Molecule, 2022 - 2028 (USD Billion)
  • 31. Germany Peptide Therapeutics Market revenue, By Technology, 2022 - 2028 (USD Billion)
  • 32. Germany Peptide Therapeutics Market revenue, By Application, 2022 - 2028 (USD Billion)
  • 33. France Peptide Therapeutics Market revenue, By Route of Administration, 2022 - 2028 (USD Billion)
  • 34. France Peptide Therapeutics Market revenue, By Type, 2022 - 2028 (USD Billion)
  • 35. France Peptide Therapeutics Market revenue, By Type of Manufacturers, 2022 - 2028 (USD Billion)
  • 36. France Peptide Therapeutics Market revenue, By Type of Molecule, 2022 - 2028 (USD Billion)
  • 37. France Peptide Therapeutics Market revenue, By Technology, 2022 - 2028 (USD Billion)
  • 38. France Peptide Therapeutics Market revenue, By Application, 2022 - 2028 (USD Billion)
  • 39. U.K. Peptide Therapeutics Market revenue, By Route of Administration, 2022 - 2028 (USD Billion)
  • 40. U.K. Peptide Therapeutics Market revenue, By Type, 2022 - 2028 (USD Billion)
  • 41. U.K. Peptide Therapeutics Market revenue, By Type of Manufacturers, 2022 - 2028 (USD Billion)
  • 42. U.K. Peptide Therapeutics Market revenue, By Type of Molecule, 2022 - 2028 (USD Billion)
  • 43. U.K. Peptide Therapeutics Market revenue, By Technology, 2022 - 2028 (USD Billion)
  • 44. U.K. Peptide Therapeutics Market revenue, By Application, 2022 - 2028 (USD Billion)
  • 45. Italy Peptide Therapeutics Market revenue, By Route of Administration, 2022 - 2028 (USD Billion)
  • 46. Italy Peptide Therapeutics Market revenue, By Type, 2022 - 2028 (USD Billion)
  • 47. Italy Peptide Therapeutics Market revenue, By Type of Manufacturers, 2022 - 2028 (USD Billion)
  • 48. Italy Peptide Therapeutics Market revenue, By Type of Molecule, 2022 - 2028 (USD Billion)
  • 49. Italy Peptide Therapeutics Market revenue, By Technology, 2022 - 2028 (USD Billion)
  • 50. Italy Peptide Therapeutics Market revenue, By Application, 2022 - 2028 (USD Billion)
  • 51. Spain Peptide Therapeutics Market revenue, By Route of Administration, 2022 - 2028 (USD Billion)
  • 52. Spain Peptide Therapeutics Market revenue, By Type, 2022 - 2028 (USD Billion)
  • 53. Spain Peptide Therapeutics Market revenue, By Type of Manufacturers, 2022 - 2028 (USD Billion)
  • 54. Spain Peptide Therapeutics Market revenue, By Type of Molecule, 2022 - 2028 (USD Billion)
  • 55. Spain Peptide Therapeutics Market revenue, By Technology, 2022 - 2028 (USD Billion)
  • 56. Spain Peptide Therapeutics Market revenue, By Application, 2022 - 2028 (USD Billion)
  • 57. Rest of Europe Peptide Therapeutics Market revenue, By Route of Administration, 2022 - 2028 (USD Billion)
  • 58. Rest of Europe Peptide Therapeutics Market revenue, By Type, 2022 - 2028 (USD Billion)
  • 59. Rest of Europe Peptide Therapeutics Market revenue, By Type of Manufacturers, 2022 - 2028 (USD Billion)
  • 60. Rest of Europe Peptide Therapeutics Market revenue, By Type of Molecule, 2022 - 2028 (USD Billion)
  • 61. Rest of Europe Peptide Therapeutics Market revenue, By Technology, 2022 - 2028 (USD Billion)
  • 62. Rest of Europe Peptide Therapeutics Market revenue, By Application, 2022 - 2028 (USD Billion)
  • 63. Asia Pacific Peptide Therapeutics Market revenue, By Route of Administration, 2022 - 2028 (USD Billion)
  • 64. Asia Pacific Peptide Therapeutics Market revenue, By Type, 2022 - 2028 (USD Billion)
  • 65. Asia Pacific Peptide Therapeutics Market revenue, By Type of Manufacturers, 2022 - 2028 (USD Billion)
  • 66. Asia Pacific Peptide Therapeutics Market revenue, By Type of Molecule, 2022 - 2028 (USD Billion)
  • 67. Asia Pacific Peptide Therapeutics Market revenue, By Technology, 2022 - 2028 (USD Billion)
  • 68. Asia Pacific Peptide Therapeutics Market revenue, By Application, 2022 - 2028 (USD Billion)
  • 69. China Peptide Therapeutics Market revenue, By Route of Administration, 2022 - 2028 (USD Billion)
  • 70. China Peptide Therapeutics Market revenue, By Type, 2022 - 2028 (USD Billion)
  • 71. China Peptide Therapeutics Market revenue, By Type of Manufacturers, 2022 - 2028 (USD Billion)
  • 72. China Peptide Therapeutics Market revenue, By Type of Molecule, 2022 - 2028 (USD Billion)
  • 73. China Peptide Therapeutics Market revenue, By Technology, 2022 - 2028 (USD Billion)
  • 74. China Peptide Therapeutics Market revenue, By Application, 2022 - 2028 (USD Billion)
  • 75. Japan Peptide Therapeutics Market revenue, By Route of Administration, 2022 - 2028 (USD Billion)
  • 76. Japan Peptide Therapeutics Market revenue, By Type, 2022 - 2028 (USD Billion)
  • 77. Japan Peptide Therapeutics Market revenue, By Type of Manufacturers, 2022 - 2028 (USD Billion)
  • 78. Japan Peptide Therapeutics Market revenue, By Type of Molecule, 2022 - 2028 (USD Billion)
  • 79. Japan Peptide Therapeutics Market revenue, By Technology, 2022 - 2028 (USD Billion)
  • 80. Japan Peptide Therapeutics Market revenue, By Application, 2022 - 2028 (USD Billion)
  • 81. India Peptide Therapeutics Market revenue, By Route of Administration, 2022 - 2028 (USD Billion)
  • 82. India Peptide Therapeutics Market revenue, By Type, 2022 - 2028 (USD Billion)
  • 83. India Peptide Therapeutics Market revenue, By Type of Manufacturers, 2022 - 2028 (USD Billion)
  • 84. India Peptide Therapeutics Market revenue, By Type of Molecule, 2022 - 2028 (USD Billion)
  • 85. India Peptide Therapeutics Market revenue, By Technology, 2022 - 2028 (USD Billion)
  • 86. India Peptide Therapeutics Market revenue, By Application, 2022 - 2028 (USD Billion)
  • 87. South Korea Peptide Therapeutics Market revenue, By Route of Administration, 2022 - 2028 (USD Billion)
  • 88. South Korea Peptide Therapeutics Market revenue, By Type, 2022 - 2028 (USD Billion)
  • 89. South Korea Peptide Therapeutics Market revenue, By Type of Manufacturers, 2022 - 2028 (USD Billion)
  • 90. South Korea Peptide Therapeutics Market revenue, By Type of Molecule, 2022 - 2028 (USD Billion)
  • 91. South Korea Peptide Therapeutics Market revenue, By Technology, 2022 - 2028 (USD Billion)
  • 92. South Korea Peptide Therapeutics Market revenue, By Application, 2022 - 2028 (USD Billion)
  • 93. South-East Asia Peptide Therapeutics Market revenue, By Route of Administration, 2022 - 2028 (USD Billion)
  • 94. South-East Asia Peptide Therapeutics Market revenue, By Type, 2022 - 2028 (USD Billion)
  • 95. South-East Asia Peptide Therapeutics Market revenue, By Type of Manufacturers, 2022 - 2028 (USD Billion)
  • 96. South-East Asia Peptide Therapeutics Market revenue, By Type of Molecule, 2022 - 2028 (USD Billion)
  • 97. South-East Asia Peptide Therapeutics Market revenue, By Technology, 2022 - 2028 (USD Billion)
  • 98. South-East Asia Peptide Therapeutics Market revenue, By Application, 2022 - 2028 (USD Billion)
  • 99. Rest of Asia Pacific Peptide Therapeutics Market revenue, By Route of Administration, 2022 - 2028 (USD Billion)
  • 100. Rest of Asia Pacific Peptide Therapeutics Market revenue, By Type, 2022 - 2028 (USD Billion)
  • 101. Rest of Asia Pacific Peptide Therapeutics Market revenue, By Type of Manufacturers, 2022 - 2028 (USD Billion)
  • 102. Rest of Asia Pacific Peptide Therapeutics Market revenue, By Type of Molecule, 2022 - 2028 (USD Billion)
  • 103. Rest of Asia Pacific Peptide Therapeutics Market revenue, By Technology, 2022 - 2028 (USD Billion)
  • 104. Rest of Asia Pacific Peptide Therapeutics Market revenue, By Application, 2022 - 2028 (USD Billion)
  • 105. Latin America Peptide Therapeutics Market revenue, By Route of Administration, 2022 - 2028 (USD Billion)
  • 106. Latin America Peptide Therapeutics Market revenue, By Type, 2022 - 2028 (USD Billion)
  • 107. Latin America Peptide Therapeutics Market revenue, By Type of Manufacturers, 2022 - 2028 (USD Billion)
  • 108. Latin America Peptide Therapeutics Market revenue, By Type of Molecule, 2022 - 2028 (USD Billion)
  • 109. Latin America Peptide Therapeutics Market revenue, By Technology, 2022 - 2028 (USD Billion)
  • 110. Latin America Peptide Therapeutics Market revenue, By Application, 2022 - 2028 (USD Billion)
  • 111. Brazil Peptide Therapeutics Market revenue, By Route of Administration, 2022 - 2028 (USD Billion)
  • 112. Brazil Peptide Therapeutics Market revenue, By Type, 2022 - 2028 (USD Billion)
  • 113. Brazil Peptide Therapeutics Market revenue, By Type of Manufacturers, 2022 - 2028 (USD Billion)
  • 114. Brazil Peptide Therapeutics Market revenue, By Type of Molecule, 2022 - 2028 (USD Billion)
  • 115. Brazil Peptide Therapeutics Market revenue, By Technology, 2022 - 2028 (USD Billion)
  • 116. Brazil Peptide Therapeutics Market revenue, By Application, 2022 - 2028 (USD Billion)
  • 117. Mexico Peptide Therapeutics Market revenue, By Route of Administration, 2022 - 2028 (USD Billion)
  • 118. Mexico Peptide Therapeutics Market revenue, By Type, 2022 - 2028 (USD Billion)
  • 119. Mexico Peptide Therapeutics Market revenue, By Type of Manufacturers, 2022 - 2028 (USD Billion)
  • 120. Mexico Peptide Therapeutics Market revenue, By Type of Molecule, 2022 - 2028 (USD Billion)
  • 121. Mexico Peptide Therapeutics Market revenue, By Technology, 2022 - 2028 (USD Billion)
  • 122. Mexico Peptide Therapeutics Market revenue, By Application, 2022 - 2028 (USD Billion)
  • 123. Rest of Latin America Peptide Therapeutics Market revenue, By Route of Administration, 2022 - 2028 (USD Billion)
  • 124. Rest of Latin America Peptide Therapeutics Market revenue, By Type, 2022 - 2028 (USD Billion)
  • 125. Rest of Latin America Peptide Therapeutics Market revenue, By Type of Manufacturers, 2022 - 2028 (USD Billion)
  • 126. Rest of Latin America Peptide Therapeutics Market revenue, By Type of Molecule, 2022 - 2028 (USD Billion)
  • 127. Rest of Latin America Peptide Therapeutics Market revenue, By Technology, 2022 - 2028 (USD Billion)
  • 128. Rest of Latin America Peptide Therapeutics Market revenue, By Application, 2022 - 2028 (USD Billion)
  • 129. The Middle-East and Africa Peptide Therapeutics Market revenue, By Route of Administration, 2022 - 2028 (USD Billion)
  • 130. The Middle-East and Africa Peptide Therapeutics Market revenue, By Type, 2022 - 2028 (USD Billion)
  • 131. The Middle-East and Africa Peptide Therapeutics Market revenue, By Type of Manufacturers, 2022 - 2028 (USD Billion)
  • 132. The Middle-East and Africa Peptide Therapeutics Market revenue, By Type of Molecule, 2022 - 2028 (USD Billion)
  • 133. The Middle-East and Africa Peptide Therapeutics Market revenue, By Technology, 2022 - 2028 (USD Billion)
  • 134. The Middle-East and Africa Peptide Therapeutics Market revenue, By Application, 2022 - 2028 (USD Billion)
  • 135. GCC Countries Peptide Therapeutics Market revenue, By Route of Administration, 2022 - 2028 (USD Billion)
  • 136. GCC Countries Peptide Therapeutics Market revenue, By Type, 2022 - 2028 (USD Billion)
  • 137. GCC Countries Peptide Therapeutics Market revenue, By Type of Manufacturers, 2022 - 2028 (USD Billion)
  • 138. GCC Countries Peptide Therapeutics Market revenue, By Type of Molecule, 2022 - 2028 (USD Billion)
  • 139. GCC Countries Peptide Therapeutics Market revenue, By Technology, 2022 - 2028 (USD Billion)
  • 140. GCC Countries Peptide Therapeutics Market revenue, By Application, 2022 - 2028 (USD Billion)
  • 141. South Africa Peptide Therapeutics Market revenue, By Route of Administration, 2022 - 2028 (USD Billion)
  • 142. South Africa Peptide Therapeutics Market revenue, By Type, 2022 - 2028 (USD Billion)
  • 143. South Africa Peptide Therapeutics Market revenue, By Type of Manufacturers, 2022 - 2028 (USD Billion)
  • 144. South Africa Peptide Therapeutics Market revenue, By Type of Molecule, 2022 - 2028 (USD Billion)
  • 145. South Africa Peptide Therapeutics Market revenue, By Technology, 2022 - 2028 (USD Billion)
  • 146. South Africa Peptide Therapeutics Market revenue, By Application, 2022 - 2028 (USD Billion)
  • 147. Rest of Middle-East Africa Peptide Therapeutics Market revenue, By Route of Administration, 2022 - 2028 (USD Billion)
  • 148. Rest of Middle-East Africa Peptide Therapeutics Market revenue, By Type, 2022 - 2028 (USD Billion)
  • 149. Rest of Middle-East Africa Peptide Therapeutics Market revenue, By Type of Manufacturers, 2022 - 2028 (USD Billion)
  • 150. Rest of Middle-East Africa Peptide Therapeutics Market revenue, By Type of Molecule, 2022 - 2028 (USD Billion)
  • 151. Rest of Middle-East Africa Peptide Therapeutics Market revenue, By Technology, 2022 - 2028 (USD Billion)
  • 152. Rest of Middle-East Africa Peptide Therapeutics Market revenue, By Application, 2022 - 2028 (USD Billion)

Methodology

FrequentlyAsked Questions

Peptide therapeutics are a class of medical drugs made from peptides, which are short chains of amino acids (the building blocks of proteins). These peptides are designed to mimic natural molecules in the body to treat diseases by interacting with specific targets like hormone receptors, enzymes, or immune system components.

The global peptide therapeutics market is expected to grow due to rising demand for targeted and biologic therapies, increasing prevalence of chronic diseases, growing advancements in peptide drug development, and expanding applications in oncology, metabolic disorders, and infectious diseases.

According to a study, the global peptide therapeutics market size was worth around USD 117.26 Billion in 2024 and is expected to reach USD 332.95 Billion by 2034.

The global peptide therapeutics market is expected to grow at a CAGR of 11% during the forecast period.

North America is expected to dominate the peptide therapeutics market over the forecast period.

Leading players in the global peptide therapeutics market include Teva Pharmaceutical Industries, AstraZeneca, Sanofi S.A, Amazen Inc., Takeda Pharmaceutical, Ipsen S.A, Merck & Co., Novo Nordisk A/S, GlaxoSmithKline plc, Ever Neuro Pharma, Eli Lilly and Company, CordenPharma International.,, among others.

The report explores crucial aspects of the peptide therapeutics market, including a detailed discussion of existing growth factors and restraints, while also examining future growth opportunities and challenges that impact the market.

Choose License Type

  • zion payment modes

List of Contents

Industry PerspectiveOverviewKey InsightsGrowth DriversRestraintsOpportunitiesChallengesReport ScopeSegmentationRecent Developments:Regional LandscapeCompetitive AnalysisThe global peptide therapeutics market is segmented as follows:

RelatedNews

HappyClients

Office Address

Contact Us

Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008

Contact #

US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

twitter

Industry Press Release

We Accept

We have secured system to process your transaction.

  • payment methods

How it Works?

Our Company

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed